Cuts May Curb Generic Use: APhA

FEBRUARY 01, 2006

The new pharmacist reimbursement formula established under the Medicaid program cuts passed by Congress late last year may result in reduced generic substitution by the nation's pharmacies, officials at the American Pharmacists Association (APhA) warned.

The controversial budget cuts "will likely have a disastrous impact on the profession's ability to provide necessary care to Medicaid patients,"APhA said in response to the legislation.

At the same time, however, the association suggested that the cutback may prove to be counterproductive by discouraging pharmacists from dispensing more cost-effective generic medicines. According to APhA, "the new payment formula, through an absence of incentives, could actually discourage the dispensing of generic drugs, a significant source of Medicaid savings."




SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.